510(k) Report

510(k) · Cleared

Recalled · 2004

DSL Active Androstenedione Ria (DSL #3800)

K854650510(k) TraditionalCleared Dec 13, 198524-day reviewClass I21 CFR 862.1075Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diagnostic Systems Laboratories, Inc. · CIZ Radioimmunoassay, Androstenedione

Cleared on Dec 13, 1985 after a 24-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled 2 times.

Decided
Dec 13, 1985
Review
24 days
Class
Class I
Product code
CIZ
Recalls
2
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K854650Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CIZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 15, 2004Not classifiedZ-0634-05OtherStandards used in the GammaCoat Androstenedione Radioimmunoassay Kit appeared yellowish in color and were gelatinous upon reconstitution.
May 25, 2004Not classifiedZ-0704-05OtherStandards contained in the GammaCoat Androstenedione RIA Kit appeared yellowish in color and were gelatinous upon reconstitution. The assay validation criteria failed when the gelatinous standards were used.

No ancestor or descendant has a Class I recall.

How does its category compare?

All CIZ devices

CIZ Radioimmunoassay, Androstenedione: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CIZ

FDA has decided no CIZ device since 2007.

Median 510(k) review, days · CIZ

Too few CIZ 510(k)s in any year since 2007 to give a median.

Recalls per year · CIZ

No recall names CIZ since 2007.

Adverse event reports per year · CIZ

1in 2017

2008: 12013: 22014: 1142016: 12017: 1
2007high 114 (2014) · low 0 (2007)2025

MAUDE reports naming product code CIZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—01
20090—00
20100—00
20110—00
20120—00
20130—02
20140—0114
20150—00
20160—01
20170—01
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “K854650: DSL Active Androstenedione Ria (DSL #3800).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K854650

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026